Physician

Benjamin Nadeau, MD

According to 2025 Medicare claims, Benjamin Nadeau, MD (NPI: 1457563728) practices hematology/oncology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37404-2744. Nadeau is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Nadeau's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 629 traditional Medicare patients, billed 156,125 HCPCS/CPT codes, and received $3,813,603 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,883 prescription claims across 307 beneficiaries totaling $5,198,631 in drug costs, led by Revlimid (Lenalidomide). DME data shows 74 claims. Open Payments data shows 9 records totaling $245. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,208,229 to $3,813,603. Similarly, Part D prescription costs have moved sharply higher in recent years, from $292,504 to $5,198,631. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,489 to $5,687.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	740	167,436	$1,208,229
2016	763	206,018	$1,543,385
2017	784	220,257	$1,825,627
2018	849	193,416	$1,727,649
2019	802	274,745	$3,574,781
2020	808	260,481	$3,316,946
2021	791	220,213	$2,948,462
2022	802	220,262	$3,673,367
2023	841	211,139	$3,689,625
2024	629	156,125	$3,813,603

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	1,188	$292,504
2016	231	1,463	$601,899
2017	233	1,576	$920,320
2018	233	1,327	$1,052,963
2019	279	1,579	$2,285,803
2020	227	1,381	$2,477,371
2021	253	1,244	$2,461,432
2022	280	1,660	$3,594,688
2023	297	1,729	$4,564,703
2024	307	1,883	$5,198,631

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	262	$10,644
2016	N/R	44	$14,922
2017	N/R	N/R	N/R
2018	N/R	31	$6,307
2019	N/R	44	$4,232
2020	N/R	55	$4,403
2021	N/R	35	$2,390
2022	N/R	33	$1,905
2023	N/R	110	$14,544
2024	N/R	74	$3,991

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	167	753	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	283	445	$87
80053	Blood test, comprehensive group of blood chemicals	353	1,423	$10
36415	Insertion of needle into vein for collection of blood sample	365	1,424	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	369	1,713	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	68	1,844	$1,150,469
Jakafi	Ruxolitinib Phosphate	35	1,050	$657,543
Xtandi	Enzalutamide	38	1,140	$504,298
Tasigna	Nilotinib Hcl	19	532	$363,711
Cabometyx	Cabozantinib S-Malate	17	488	$310,231

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$2,839
J8700	Temozolomide, oral, 5 mg	N	N/R	20	$694
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$176

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$245	Aveo Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Nadeau, MD?

Tedicare shows public-source Medicare data for Benjamin Nadeau, MD (NPI 1457563728), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Nadeau, MD have ACO affiliation data?

Benjamin Nadeau, MD is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Benjamin Nadeau, MD?

Benjamin Nadeau, MD is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Benjamin Nadeau, MD have Open Payments data?

Benjamin Nadeau, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.